• Contact Us
  • Register
  • Sign In
PHACS PHACS
  • Home
  • About Us
    • Mission and Values
    • Leadership
    • Our Clinical Sites
    • Participating Organizations
    • Funding
    • Clinical Site Feature Profiles
    • PHACS Puerto Rico Hurricane Relief
    • Inspiration Hub
    • In Memoriam
    • Contact Us
  • Our Research
    • Studies
    • Support Cores
    • Working Groups and Task Forces
    • Resources for Researchers
    • The George R. Seage III Early Career Investigator Award
    • Emerging Research Pilots
    • Research Network Partners
    • Collaborate with Us
    • Participate in the Study
    • Non-Disclosure Agreement (NDA)
  • Findings
    • Publications
    • PHACS in the News
    • Infographics Series
    • Research Summaries
    • Resúmenes de las Investigaciones
  • Community
    • Adult Community Advisory Board
    • Peers United Group (PUG)/YACAB
    • Health Education Resources
    • PHACS Film Series
    • "Just the PHACS" Digest
    • Glossary
  • Contact Us
  • Register
  • Sign In
  • You are here:  
  • Home

Dr. Russell Van Dyke

Title and Affiliation
Professor of Pediatrics and Head, Section of Infectious Diseases
Tulane University School of Medicine
Contact: vandyke@tulane.edu 
 

PHACS Roles
Founding Co-Principal Investigator
Co-Chair, AMP Up Series Protocol
Co-Chair, Complications Working Group 

Dr. Russell Van Dyke, MD graduated from Stanford University in 1971 with a BA in Biology.  He received his MD degree from the Medical College of Wisconsin in 1975. He completed a residency in pediatrics at the University of California, San Diego, where he served as chief resident.   He then did a fellowship in Pediatric Infectious Diseases at the University of California, San Diego, where he worked in the laboratory of Dr. James Connor. In 1983 he joined the faculty of the Tulane University Department of Pediatrics, where he became head of the Section of Pediatric Infectious Diseases in 1995 and Professor of Pediatrics in 1995. His research interests include the management and epidemiology of HIV-infected and HIV-exposed children and youth, prevention of mother-to-child transmission of HIV, and antiviral chemotherapy.   He directs the Tulane Pediatric AIDS Clinical Trials Unit, which was funded as an NIH International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) clinical site from 1990-2015. Since 2005, he has been principal investigator of the Coordinating Center of the NIH-funded Pediatrics HIV/AIDS Cohort Study (PHACS), a multi-centered longitudinal cohort study of HIV-infected and HIV-exposed infants and children. He is also the site PI for the PHACS SMARTT study of the long-term safety of in utero exposure to antiretroviral agents.  He has served as chair of the Working Group on Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected Children of the CDC and NIH and co-chair of the DHHS Panel on Pediatric Antiretroviral Therapy and Management Guidelines of the NIH.  He has also served on the FDA Antiviral Drugs Advisory Committee.

Read Dr. Van Dyke's full bio here >>

About Us
Mission and Values
Leadership
Our Clinical Sites
Participating Organizations
Funding
Clinical Site Feature Profiles
PHACS Puerto Rico Hurricane Relief
Inspiration Hub
In Memoriam
Contact Us

Confidentiality Policy   |   Terms of Use   |   Powered by SiteRocket Labs

National Institutes of Health

Introducing the PHACS Member Area (BETA)